Treatment of Compound Tibia Fracture With a Microvascular Latissimus Dorsi Flap and the Ilizarov Technique
NCT ID: NCT02369991
Last Updated: 2015-05-14
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
9 participants
OBSERVATIONAL
2014-06-30
2015-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Reconstruction of Extensive Upper Extremity Long Bone Defects With a Microvascular Fibula Flap
NCT02372838
Ilizarov Frame or Uni Planar External Fixator in the Cost-conscious Era
NCT03936972
Conservative Versus Intramedullary Nailing for Pediatric Tibial Shaft Fractures
NCT05501496
The Infected Bone Nonunion and Soft Tissue Defect of Long Bone Treated Simultaneously With Ilizarov Technique
NCT00846261
Evaluation of the Change in Length of the Leg in Children After Treatment of Femur Fractures.
NCT00355420
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CROSS_SECTIONAL
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Reconstructive surgery
Patients were treated with free latissimus dorsi flap and bone transport technique
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients with acute compound tibial fracture or sequela treated with free latissimus dorsi flap and bone transport.
Exclusion Criteria
* Patients under 15 years of age.
15 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Helsinki University Central Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jussi Repo
Researcher
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Erkki J. Tukiainen, PhD, MD
Role: STUDY_DIRECTOR
Helsinki University Hospital, Department of Plastic and Reconstructive Surgery.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Helsinki University Central Hospital
Helsinki, Uusimaa, Finland
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
343/13/03/02/2013/4
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.